Genovaris Medicalsp. z o.o.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2025-08-08
Share capital
5 000,00 PLN
Activity description

Genovaris Medical is a company that offers hydrogel patches designed to treat acne and skin irritations. Their product features snail mucin and provides 24-hour skin care and regeneration. The patches are marketed as safe for sensitive skin and are available for purchase at a price of 10 PLN.

Registered address
ul. Frezerów 2, 20-213 Lublin, Poland
Website
genovaris.comWebsite active
Email
Email address current
Phone
Electronic delivery address
AE:PL-15799-12584-JEAWU-13

Financials

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 25.11MedianUSD 126.89kAverageUSD 4.67m
Net profit
This companyUSD 16.49MedianUSD -19.64AverageUSD 371.62k
Operating costs
This companyUSD 6.78MedianUSD 165.83kAverageUSD 4.01m
Assets
This companyUSD 13.83kMedianUSD 251.40kAverageUSD 7.40m

Bank accounts

Registered as a VAT taxpayer on 2025-09-10. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
—
De minimis aid (in accordance with Commission Regulation 2023/2831)
—

Tenders

No recorded participation in tenders.

Authorized Representatives

Dariusz Sulej — President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Ewa Joanna Sulej (47)
90$1,215.5690%
Oliver Sulej (19)
10$135.0610%

Ewa Joanna Sulej and Oliver Sulej hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person
Ewa Joanna Sulej (47)

Competitors

Name
NanotheaS.A.

Change history

DateEvent
2026-09-11Address change
2025-08-08Entered in the register

FAQ

Last updated: 2026-10-03